Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2
Just came across the article of MarketWatch:

http://www.ftmarketwatch.com/news/story.asp?guid=%7B17a3d44c-2b2a-4e4e-8334-e8b3ea18fae8%7D

In my opinion, it warrants close attention for Genentech shareholders. As one of the group leaders in the TMF Biotech Investing seminar, I know that many people who first investigate Genentech have reservations about the relationship between Genentecha and Roche. My research indicates that current Roche management is quite content to let Genentech manage its own affairs. But a change in ownership could lead to a change in management, which could lead to a change in this relationship.

For the moment, at least, we don't have to worry about a hostile takeover: "The Hoffmann and Oeri-Hoffmann families own 50.1 percent of Roche, giving them to (sic) block any attempt by Novartis to carry out a hostile takeover."

Doug
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.